The sensitivity and specificity of CD200 expression in CLL diagnosis was 79.5% and 87.3%, respectively when CD200 expression was measured by positive rate (AUC = 0.89, Figure 2A). This evidence concerns the gene CD200 and B-cell chronic lymphocytic leukemia.